ClinicalTrials.gov
ClinicalTrials.gov Menu

Urinary Prostaglandin E Metabolite (PGE-M), A Metabolite of Prostaglandin E2 (PGE2): A Novel Biomarker of Crohn's Disease Activity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00496548
Recruitment Status : Completed
First Posted : July 4, 2007
Last Update Posted : May 2, 2017
Sponsor:
Collaborator:
UCB Pharma
Information provided by (Responsible Party):
David Schwartz, Vanderbilt University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2015
  Actual Study Completion Date : December 2015